Estados financieros detallados de Silo Pharma, Inc. (SILO): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
Márgenes de los últimos 12 meses: margen bruto -474.3%, margen operativo -82.5%, margen neto -82.7%.
Al precio actual de $1.76, SILO presenta beneficios negativos (P/E no significativo) y un ROE del -81.74%. La capitalización bursátil es de $2M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | -$669480 | $847407 | 0 | $40569 | 0 | $71264 | $72102 | $72102 | $72102 | $72102 |
| Coste de Ventas | 0 | 0 | $17550 | $27387 | 0 | $5004 | $5838 | $5838 | $5838 | $886057 |
| Beneficio Bruto | -$669480 | $847407 | -$17550 | $13182 | 0 | $66260 | $66264 | $66264 | $66264 | -$813955 |
| I+D | 0 | 0 | 0 | $63465 | $26250 | $693910 | $1.3M | $845092 | $2.4M | $2.2M |
| Generales y Administrativos | $300994 | $313371 | $459830 | $864180 | $2.2M | $2.3M | $2.4M | $3.1M | $2.4M | $2.1M |
| Gastos Operativos | $443494 | $490871 | $459830 | $943585 | $2.2M | $2.8M | $3.7M | $3.9M | $4.8M | $3.5M |
| Beneficio Operativo | -$393658 | -$470388 | -$594242 | -$930403 | -$2.2M | -$2.7M | -$3.6M | -$3.9M | -$4.7M | -$4.3M |
| EBITDA | 0 | $356536 | -$951914 | -$950366 | -$2.4M | $4.2M | -$3.9M | -$3.6M | -$4.4M | -$4.2M |
| Gastos por Intereses | 0 | 0 | 0 | $62928 | $269267 | $3036 | $2199 | $4869 | $5084 | $37302 |
| Beneficio Antes de Impuestos | -$1.1M | $356536 | -$969463 | -$1.0M | -$2.7M | $4.2M | -$3.9M | -$3.6M | -$4.4M | -$4.2M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | $24876 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$1.1M | $356536 | -$969463 | -$1.0M | -$3.0M | $3.9M | -$3.9M | -$3.7M | -$4.4M | -$4.2M |
| BPA | $-16.65 | $7.50 | $-14.85 | $-18.60 | $-35.25 | $19.80 | $-25.65 | $-18.00 | $-17.85 | $-7.50 |
| BPA Diluido | $-16.65 | $7.50 | $-14.85 | $-18.60 | $-35.25 | $19.50 | $-25.65 | $-18.00 | $-17.85 | $-7.50 |
| Acciones en Circulación (Diluidas) | $66928 | $69443 | $65469 | $56153 | $87940 | $127896 | $152283 | $205325 | $245359 | $558818 |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $18025 | $18026 | $18026 | 0 |
| Beneficio Bruto | -$2662 | -$2663 | -$248232 | -$2938 |
| Beneficio Operativo | -$1.2M | -$786524 | -$1.6M | -$928949 |
| EBITDA | -$1.1M | -$845891 | -$1.6M | -$988779 |
| Beneficio Neto | -$1.1M | -$881530 | -$1.6M | -$832829 |
| BPA | $-1.80 | $-0.99 | $-1.80 | $-0.76 |
| BPA Diluido | $-1.80 | $-0.99 | $-1.80 | $-0.76 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $579209 | $294591 | $336679 | $111752 | $1.1M | $9.8M | $11.4M | $3.5M | $3.9M | $4.7M |
| Inversiones a Corto | 0 | 0 | $228294 | $9394 | $200 | $419995 | $3118 | $4.1M | $3.2M | $2.1M |
| Cuentas por Cobrar | $58549 | 0 | 0 | $200000 | $23500 | 0 | $66010 | 0 | 0 | 0 |
| Inventario | 0 | 0 | $26973 | $156366 | $33484 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $664731 | $1.6M | $625977 | $493845 | $1.4M | $10.4M | $11.6M | $7.7M | $7.1M | $7.4M |
| Inmovilizado Material | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | $29440 | 0 | 0 | 0 | 0 | 0 | $241215 | $217375 |
| Activos Totales | $1.3M | $1.6M | $855417 | $493845 | $1.4M | $10.5M | $11.6M | $7.7M | $7.4M | $7.6M |
| Cuentas por Pagar | $53098 | $38343 | $25631 | $54862 | $127069 | $417937 | $364216 | $703488 | $1.6M | $578081 |
| Deuda a Corto | 0 | 0 | $22344 | $61875 | $14654 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Corrientes | $53098 | $38343 | $47975 | $116737 | $141723 | $490039 | $436318 | $775590 | $1.7M | $650183 |
| Deuda a Largo | 0 | 0 | 0 | 0 | $4246 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $453098 | $438343 | $447975 | $516737 | $145969 | $1.4M | $1.3M | $1.6M | $2.4M | $1.3M |
| Reservas | -$400000 | -$470388 | -$1.6M | -$2.7M | -$5.8M | -$3.3M | -$7.2M | -$10.9M | -$15.3M | -$19.5M |
| Patrimonio Neto | $846506 | $1.2M | $407442 | -$22892 | $1.3M | $9.1M | $10.3M | $6.2M | $5.0M | $6.3M |
| Deuda Total | 0 | 0 | $22344 | $61875 | $18900 | 0 | 0 | 0 | 0 | 0 |
| Deuda Neta | -$579209 | -$294591 | -$542629 | -$59271 | -$1.1M | -$10.3M | -$11.4M | -$7.7M | -$7.1M | -$6.9M |
| Capital Circulante | $611633 | $1.6M | $578002 | $377108 | $1.3M | $9.9M | $11.1M | $6.9M | $5.5M | $6.7M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $3.9M | $4.7M | $3.9M | $3.3M |
| Activos Totales | $6.4M | $7.6M | $7.0M | $6.0M |
| Pasivos Totales | $1.4M | $1.3M | $1.3M | $1.1M |
| Patrimonio Neto | $5.0M | $6.3M | $5.7M | $4.9M |
| Deuda Total | 0 | 0 | 0 | 0 |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$1.1M | $356536 | -$969463 | -$1.0M | -$3.0M | $4.2M | -$3.9M | -$3.7M | -$4.4M | -$4.2M |
| Amortizaciones | 0 | 0 | $17550 | 0 | 0 | 0 | 0 | 0 | $6185 | $11440 |
| Compensación en Acciones | 0 | 0 | 0 | $177960 | $1.2M | 0 | $156047 | $14125 | 0 | $117021 |
| Cambio en Capital Circulante | -$89378 | -$34708 | -$16797 | -$82464 | -$72138 | $704751 | -$75288 | $299275 | $551756 | -$1.2M |
| Flujo de Caja Operativo | -$143555 | -$284618 | $272637 | -$794324 | -$1.2M | -$2.3M | -$3.5M | -$3.2M | -$3.8M | -$4.7M |
| Inversiones (CapEx) | 0 | 0 | 0 | 0 | 0 | -$4 | 0 | 0 | 0 | 0 |
| Adquisiciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Recompra de Acciones | 0 | 0 | -$2872 | 0 | 0 | 0 | 0 | -$471121 | -$173113 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$143555 | -$284618 | $272637 | -$794324 | -$1.2M | -$2.3M | -$3.5M | -$3.2M | -$3.8M | -$4.7M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$955493 | -$780278 | -$822623 | -$781861 |
| Inversiones (CapEx) | $3 | 0 | $3 | 0 |
| Flujo de Caja Libre | -$955490 | -$780278 | -$822620 | -$781861 |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $47267 | $52309 | 0 | $39174 |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | +226.6% | -100.0% | | -100.0% | | +1.2% | +0.0% | +0.0% | +0.0% |
| Crecimiento Beneficio Neto (anual) | | +132.0% | -371.9% | -4.5% | -199.8% | +228.5% | -200.1% | +5.3% | -18.7% | +3.8% |
| Crecimiento BPA (anual) | | +145.0% | -298.0% | -25.3% | -89.5% | +156.2% | -229.5% | +29.8% | +0.8% | +58.0% |
| Cambio en Acciones (anual) | | +3.8% | -5.7% | -14.2% | +56.6% | +45.4% | +19.1% | +34.8% | +19.5% | +127.8% |
| Crecimiento FCF (anual) | | -98.3% | +195.8% | -391.3% | -45.7% | -96.9% | -53.5% | +7.8% | -18.9% | -21.6% |
| Margen Bruto | 100.0% | 100.0% | | 32.5% | | 93.0% | 91.9% | 91.9% | 91.9% | -1128.9% |
| Margen Operativo | 58.8% | -55.5% | | -2293.4% | | -3851.0% | -5031.3% | -5347.4% | -6526.4% | -5937.0% |
| Margen EBITDA | -0.0% | 42.1% | | -2342.6% | | 5872.6% | -5416.2% | -5029.3% | -6077.0% | -5795.9% |
| Margen Neto | 166.2% | 42.1% | | -2497.7% | | 5477.9% | -5420.9% | -5132.6% | -6092.6% | -5863.5% |
| Margen FCF | 21.4% | -33.6% | | -1958.0% | | -3196.6% | -4850.9% | -4472.1% | -5317.3% | -6464.9% |
| Tasa Impositiva Efectiva | -0.0% | 0.0% | -0.0% | -0.0% | -0.0% | 0.6% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-2.14 | $-4.10 | $4.16 | $-14.15 | $-13.16 | $-17.81 | $-22.97 | $-15.70 | $-15.63 | $-8.34 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $66928 | $66777 | $65469 | $56153 | $87940 | $126488 | $152283 | $205325 | $245359 | $558818 |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -81.74% |
| Rentabilidad sobre capital invertido | -91.31% |
| Rentabilidad sobre activos | -75.13% |
| Margen bruto | -474.31% |
| Margen operativo | -8250.46% |
| Margen neto | -8269.53% |
Salud financiera
| Deuda / Patrimonio | 0.00 |
| Ratio corriente | 5.36 |
| Piotroski F-Score | 2 |
| Altman Z-Score | -3.06 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -15.77 | 35.00 | -17.68 | -14.11 | -7.45 | 5.42 | -1.96 | -1.20 | -0.75 | -0.68 |
| P/VC | 20.75 | 14.57 | 42.18 | -643.90 | 18.02 | 1.50 | 0.74 | 0.72 | 0.65 | 0.45 |
| P/V | -26.24 | 20.69 | 0.00 | 363.34 | 0.00 | 190.36 | 106.45 | 61.51 | 45.43 | 39.53 |
| Margen Bruto | 100.0% | 100.0% | 0.0% | 32.5% | 0.0% | 93.0% | 91.9% | 91.9% | 91.9% | -1128.9% |
| Margen Operativo | 58.8% | -55.5% | 0.0% | -2293.4% | 0.0% | -3851.0% | -5031.3% | -5347.4% | -6526.4% | -5937.0% |
| Margen Neto | 166.2% | 42.1% | 0.0% | -2497.7% | 0.0% | 5477.9% | -5420.9% | -5132.6% | -6092.6% | -5863.5% |